Publicaciones (21) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia

    JAMA Dermatology, Vol. 155, Núm. 6, pp. 724-728

  2. Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Churg-Strauss syndrome and pregnancy. Case report and bibliographic review.

    Ginecologia y Obstetricia de Mexico, Vol. 87, Núm. 11, pp. 756-761

  4. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials

    Diabetes and Metabolism, Vol. 45, Núm. 5, pp. 409-418

  5. Cost of achieving hba1c and weight loss treatment targets with ideglira vs insulin glargine u100 plus insulin aspart in the usa

    ClinicoEconomics and Outcomes Research, Vol. 11, pp. 271-282

  6. Document on a comprehensive approach to type 2 diabetes mellitus

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 7, pp. 443-458

  7. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial

    JACC: Cardiovascular Imaging, Vol. 12, Núm. 7, pp. 1188-1198

  8. Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 6, pp. 1506-1512

  9. Hair disorders in cancer survivors

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1199-1213

  10. Hair disorders in patients with cancer

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1179-1196

  11. IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 12, pp. 2643-2650

  12. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

  13. In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy

    Anais Brasileiros de Dermatologia, Vol. 94, Núm. 1, pp. 93-95

  14. Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, Núm. 3, pp. 237-243

  15. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

  16. Realización de un seminario práctico de toma de decisiones obstétricas con formato de concurso por equipos. Experiencia piloto con estudiantes de medicina

    FEM. Revista de la Fundación Educación Médica, Vol. 22, Núm. 4, pp. 165-168

  17. Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects with Type 2 Diabetes on Semaglutide

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 9, pp. 4078-4086

  18. Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

    Breast Cancer Research and Treatment, Vol. 174, Núm. 1, pp. 15-26

  19. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

  20. Treatment outcomes of immune-related cutaneous adverse events

    Journal of Clinical Oncology, Vol. 37, Núm. 30, pp. 2746-2758